Table 3.
Non-CRC LS-associated tumors in LS and LLS patients and their FDR.
| Location of the Tumors | LS Families | LLS Families | p Value |
|---|---|---|---|
| Number of Tumors: 184 | Number of Tumors: 40 | ||
| Ovary | 20 (10.9%) | 5 (12.5%) | n.s. |
| Endometrium | 89 (48.4%) | 8 (20.0%) | 0.001 |
| Pancreas | 6 (3.3%) | 6 (15.0%) | 0.003 |
| Stomach | 37 (20.1%) | 11 (27.5%) | n.s. |
| Urinary tract | 10 (5.4%) | 4 (10%) | n.s. |
| Skin | 3 (1.6%) | 2 (5%) | n.s. |
| Small intestine | 5 (2.7%) | 0 (0%) | n.s. |
| Brain | 6 (3.3%) | 2 (5%) | n.s. |
| Biliary tract | 8 (4.3%) | 2 (5%) | n.s. |
p < 0.05. LS, Lynch syndrome; LLS, Lynch-like syndrome; CRC, colorectal cancer; n.s., no significative.